アンジオテンシンタイプ2受容体を介した血管弛緩機構

  • 屋山 勝俊
    神戸学院大学薬学部生命薬学部門循環器薬理学研究室
  • 岡本 博
    神戸学院大学薬学部生命薬学部門循環器薬理学研究室

書誌事項

タイトル別名
  • Angiotensin Type 2 Receptor-Dependent Vasodilation
  • アンジオテンシン タイプ 2 ジュヨウタイ オ カイシタ ケッカン シカン キコウ

この論文をさがす

抄録

  Angiotensin II (Ang II) signaling is mediated by two receptor subtypes, type 1 (AT1) and type 2 (AT2). The activation of AT1 receptors is responsible for the development of Ang II-dependent hypertension, whereas the activation of AT2 receptor is thought to play a counter-regulatory protective role in the regulation of blood pressure that opposes the AT1 receptor-mediated vasoconstriction. However, the precise mechanisms by which increased numbers of AT2 receptors counterbalance the AT1-mediated actions of Ang II are unknown. We have demonstrated that the abdominal aortic banding in mice and rats and the 2-kidney, 1-clip Goldblatt model of hypertension in mice induces up-regulation of AT2 receptors in the pressure-overloaded thoracic aorta. In these hypertensive animals, the AT1-receptor antagonists but not calcium antagonist abolish up-regulation of the aortic AT2 receptor as well as blood pressure elevation, suggesting that the pressure-overload up-regulates the aortic AT2 receptor by Ang II via the activation of AT1 receptor. Ang II binding to up-regulated AT2 receptors induces vasodilation in these aortas through bradykinin B2-receptor-mediated phosphorylation of endothelial nitric oxide synthase (eNOS) at Ser633 and Ser1177 via a protein kinase A-dependent signaling pathway, resulting in sustained production of nitric oxide. These studies provide evidence that the vascular AT2 receptor is up-regulated in the course of hypertension through the activation of AT1 receptor, thereby activating a vasodilatory pathway in vessels through the AT2 receptor via the bradykinin/nitric oxide/cGMP. This issue is important because the antihypertensive effect of AT1-receptor blockers is, at least in part, dependent on AT2-receptor activation.<br>

収録刊行物

  • 薬学雑誌

    薬学雑誌 127 (9), 1357-1367, 2007-09-01

    公益社団法人 日本薬学会

被引用文献 (3)*注記

もっと見る

参考文献 (51)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ